Vol 9, No 6 (2020)
Letter to the Editor
Published online: 2020-12-02

open access

Page views 399
Article views/downloads 561
Get Citation

Connect on Social Media

Connect on Social Media

Is there a need for a treatment for COVID-19-induced diabetes?

Antonio Vitiello1, Francesco Ferrara1
Clin Diabetol 2020;9(6):378.

Abstract

n/a

Article available in PDF format

View PDF Download PDF file

References

  1. Li J, Wang X, Chen J, et al. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020 [Epub ahead of print].
  2. Hamming I, Timens W, Bulthuis MLC, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2): 631–637.
  3. Yang JK, Lin SS, Ji XJ, et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010; 47(3): 193–199.
  4. Vitiello A, Ferrara F. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know? Eur J Pharmacol. 2020; 883: 173373.
  5. Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020; 9(1): 601–604.
  6. Qi F, Qian S, Zhang S, et al. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020; 526(1): 135–140.
  7. Waumans Y, Baerts L, Kehoe K, et al. The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis. Front Immunol. 2015; 6: 387.
  8. Ferrara F, Vitiello A. The impact of COVID-19 in diabetic patient. Arch Med Health Sci. 2020; 8(1): 167–171.